Bausch + Lomb Advances Novel Oral Treatment for Dry AMD Following Constructive FDA Meeting
Bausch + Lomb Corporation announced progress in the development of BL1243 (tonabersat), an investigational oral…
Bausch + Lomb Corporation announced progress in the development of BL1243 (tonabersat), an investigational oral…
